Trump Officials Move to Lower Drug Prices by Passing On Rebates to Patients
The change would disrupt longstanding payment arrangements in the pharmaceutical industry, which could lower patients’ costs but could also have unintended consequences.
from NYT > Politics https://nyti.ms/2GgyzP5
from NYT > Politics https://nyti.ms/2GgyzP5
Comments
Post a Comment